| abstract |
The present invention relates to a method of controlling secretions in and around the eye of a patient by administering a purine receptor agonist such as any uridine, adenine or cytidine triphosphate as well as other nucleoside phosphate compounds, ≪ / RTI >n n n The method comprises administering an effective amount of uridine 5'-triphosphate [UTP], dinucleotide, cytidine 5'-triphosphate [CTP], adenosine 5'-triphosphate Comprising administering to a subject's ocular surface a purine receptor agonist such as [ATP] or a pharmaceutically acceptable analogue and derivative thereof,n n n Methods of administering the pharmaceutical formulations include topical administration via liquid, gel, cream or contact lenses or selective release membranes; Or by inhalation by means of a non-point or spray, spray or other device, oral form (liquid or pill), injectable intraoperative eye drops or tissue administration by the form of suppositories. |